Cationic polypeptide micelle-based antigen delivery system: A simple and robust adjuvant to improve vaccine efficacy

Journal of Controlled Release

Volumn 170, Issue 2, 2013, Pages 259-267

  Luo, Zichao ^a   Li, Ping ^a   Deng, Jizhe ^a   Gao, Ningning ^a   Zhang, Yijuan ^a   Pan, Hong ^a   Liu, Lanlan ^a   Wang, Ce ^a   Cai, Lintao ^a   Ma, Yifan ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Antibody production; Cytotoxic T lymphocyte response; Dendritic cells; Polypeptide micelles; Vaccine adjuvant

Indexed keywords

AMINO ACIDS; ANTIBODIES; ANTIGENS; CELLS; LYMPHOCYTES; MICELLES; PHASE LOCKED LOOPS; POLYETHYLENE GLYCOLS; POLYPEPTIDES; T-CELLS;

ANTIBODY PRODUCTION; ANTIGEN DELIVERY SYSTEM; CYTOTOXIC T LYMPHOCYTES; DENDRITIC CELLS; INNOVATIVE STRATEGIES; LOADING CAPACITIES; VACCINE ADJUVANTS; VACCINE DELIVERY SYSTEM;

VACCINES;

LEUCINE; MACROGOL; OVALBUMIN; POLYCYTIDYLIC ACID; POLYLYSINE; SUBUNIT VACCINE; ANTIGEN; CYTOKINE; MICELLE; PEPTIDE; VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GERMINAL CENTER; HYBRID; IN VITRO STUDY; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; FEMALE; GERMINAL CENTER; MICE; MICE, INBRED C57BL; MICELLES; OVALBUMIN; PEPTIDES; VACCINES;

EID: 84879488500     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.05.027     Document Type: Article

References (45)

1. R.L. Coffman, A. Sher, R.A. Seder, Vaccine adjuvants: putting innate immunity to work, Immunity 33 (2010) 492-503.
2. ML De Temmerman, J. Rejman, J. Demeester, D.J. Irvine, B. Gander, S.C De Smedt, Particulate vaccines: on the quest for optimal delivery and immune response, Drug Discov. Today 16 (2011) 569-582.
3. C. Foged, J. Hansen, E.M. Agger, License to kill: formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems, Eur. J. Pharm. Sci. 45 (2012) 482-491.
4. N. Garcon, M. Van Mechelen, Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems, Expert Rev. Vaccine 10 (2011) 471-486.
5. D.T. O'Hagan, E. De Gregorio, The path to a successful vaccine adjuvant - 'the long and winding road', Drug Discov. Today 14 (2009) 541-551.
6. S.A. Ferreira, F.M. Gama, M. Vilanova, Polymeric nanogels as vaccine delivery systems, Nanomedicine 9 (2012) 159-173.
7. M. Look, A. Bandyopadhyay, J.S. Blum, T.M. Fahmy, Application of nanotechnol-ogies for improved immune response against infectious diseases in the developing world, Adv. Drug Deliv. Rev. 62 (2010) 378-393.
8. B.G. De Geest, M.A. Willart, H. Hammad, B.N. Lambrecht, C Pollard, P. Bogaert, M. De Filette, X. Saelens, C. Vervaet, J.P. Remon, J. Grooten, S. De Koker, Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection, ACS Nano 6 (2012) 2136-2149.
9. Y. Zhuang, Y. Ma, C. Wang, L. Hai, C. Yan, Y. Zhang, F. Liu, L. Cai, PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution, J. Control. Release 159 (2012) 135-142.
10. J.J. Moon, H. Suh, A. Bershteyn, M.T. Stephan, H. Liu, B. Huang, M. Sohail, S. Luo, S.H. Um, H. Khant, J.T. Goodwin, J. Ramos, W. Chiu, D.J. Irvine, Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses, Nat. Mater. 10 (2011) 243-251.
11. E.A. Scott, A. Stano, M. Gillard, A.C. Maio-Liu, M.A. Swartz, J.A. Hubbell, Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes, Biomaterials 33 (2012) 6211-6219.
12. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, J.A. Hubbell, Exploiting lymphatic transport and complement activation in nanoparticle vaccines, Nat. Biotechnol. 25 (2007) 1159-1164. (Pubitemid 47538111)
13. S.L. Demento, W. Cui, J.M. Criscione, E. Stern, J. Tulipan, S.M. Kaech, T.M. Fahmy, Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype, Biomaterials 33 (2012) 4957-4964.
14. C. Wang, Y. Zhuang, Y. Zhang, Z. Luo, N. Gao, P. Li, H. Pan, L. Cai, Y. Ma, Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells, Vaccine 30 (2012) 4790-4799.
15. C.M. Jewell, S.C. Lopez, D.J. Irvine, In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 15745-15750.
16. F. Sarti, G. Perera, F. Hintzen, K. Kotti, V. Karageorgiou, O. Kammona, C. Kiparissides, A. Bernkop-Schnurch, In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A, Biomaterials 32 (2011) 4052-4057.
17. Z.L. Tyrrella, Y. Shena, M. Radosza, Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers, Prog. Polym. Sci. 35 (2010) 1128-1143.
18. N. Rapoport, Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery, Prog. Polym. Sci. 32 (2007) 962-990. (Pubitemid 47198285)
19. X.B. Xiong, A. Falamarzian, S.M. Garg, A. Lavasanifar, Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery, J. Control. Release 155 (2011) 248-261.
20. A. Kano, K. Moriyama, T. Yamano, I. Nakamura, N. Shimada, A. Maruyama, Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA, J. Control. Release 149 (2011) 2-7.
21. A. Boudier, A. Aubert-Pouessel, P. Louis-Plence, C. Gerardin, C. Jorgensen, J.M. Devoisselle, S. Begu, The control of dendritic cell maturation by pH-sensitive polyion complex micelles, Biomaterials 30 (2009) 233-241.
22. A. Boudier, A. Aubert-Pouessel, N. Mebarek, A. Chavanieu, J. Quentin, D. Martire, H. Boukhaddaoui, C. Gerardin, C. Jorgensen, J.M. Devoisselle, P. Louis-Plence, S. Begu, Development of tripartite polyion micelles for efficient peptide delivery into dendritic cells without altering their plasticity, J. Control. Release 154 (2011) 156-163.
23. A.K. Jain, A.K. Goyal, P.N. Gupta, K. Khatri, N. Mishra, A. Mehta, S. Mangal, S.P. Vyas, Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B, J. Control. Release 136 (2009) 161-169.
24. A.K. Jain, A.K. Goyal, N. Mishra, B. Vaidya, S. Mangal, S.P. Vyas, PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B, Int. J. Pharm. 387 (2010) 253-262.
25. J. Deng, N. Gao, Y. Wang, H. Yi, S. Fang, Y. Ma, L. Cai, Self-assembled cationic micelles based on PEG-PLL-PLLeu hybrid polypeptides as highly effective gene vectors, Biomacromolecules 13 (2012) 3795-3804.
26. S. Son, R. Namgung, J. Kim, K. Singha, W.J. Kim, Bioreducible polymers for gene silencing and delivery, Acc. Chem. Res. 45 (2012) 1100-1112.
27. Y. Xu, Y. Du, Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles, Int. J. Pharm. 250 (2003) 215-226. (Pubitemid 35447951)
28. Y. Ma, Y. Zhuang, X. Xie, C. Wang, F. Wang, D. Zhou, J. Zeng, L. Cai, The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses, Nanoscale 3 (2011) 2307-2314.
29. Y. Ma, A.C. Ross, Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response, Clin. Vaccine Immunol. 16 (2009) 1476-1484.
30. M. Amidi, S.G. Romeijn, J.C. Verhoef, H.E. Junginger, L. Bungener, A. Huckriede, D.J. Crommelin, W. Jiskoot, N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and im-munogenicity in a mouse model, Vaccine 25 (2007) 144-153. (Pubitemid 44855251)
31. P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, M.J. Alonso, Chitosan and chitosan/ ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines, Pharm. Res. 14 (1997) 1431-1436. (Pubitemid 27481075)
32. D. Doroud, S. Rafati, Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems, Expert Rev. Vaccine 11 (2012) 69-86.
33. G. Sahay, D.Y. Alakhova, A.V. Kabanov, Endocytosis of nanomedicines, J. Control. Release 145 (2010) 182-195.
34. S. Xu, B.Z. Olenyuk, C.T. Okamoto, S.F. Hamm-Alvarez, Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances, Adv. Drug Deliv. Rev. 65 (2012) 121-138.
35. S. Zhao, W. Dai, B. He, J. Wang, Z. He, X. Zhang, Q. Zhang, Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms, J. Control. Release 158 (2012) 413-423.
36. S. Hamdy, A. Haddadi, R.W. Hung, A. Lavasanifar, Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations, Adv. Drug Deliv. Rev. 63 (2011) 943-955.
37. C.K. Tang, K.C. Sheng, S.E. Esparon, O. Proudfoot, V. Apostolopoulos, G.A. Pietersz, Molecular basis of improved immunogenicity in DNA vaccination mediated by a mannan based carrier, Biomaterials 30 (2009) 1389-1400.
38. S.A. Ghanekar, L.E. Nomura, M.A. Suni, L.J. Picker, H.T. Maecker, V.C. Maino, Gamma interferon expression in CD8(+) T cells is a marker for circulating cyto-toxic T lymphocytes that recognize an HLA A2-restricted epitope of human cyto-megalovirus phosphoprotein pp 65, Clin. Diagn. Lab. Immunol. 8 (2001) 628-631. (Pubitemid 32428893)
39. M.M. Moretto, E.M. Lawlor, I.A. Khan, Lack of interleukin-12 in p40-deficient mice leads to poor CD8+ T-cell immunity against Encephalitozoon cuniculi infection, Infect. Immun. 78 (2010) 2505-2511.
40. J. Purkerson, P. Isakson, A two-signal model for regulation of immunoglobulin isotype switching, FASEB J. 6 (1992) 3245-3252.
41. S.L. Nutt, D.M. Tarlinton, Germinal center B and follicular helper T cells: siblings, cousins or just good friends [quest], Nat. Immunol. 12 (2011) 472-477.
42. S.L. Demento, N. Bonafe, W. Cui, S.M. Kaech, M.J. Caplan, E. Fikrig, M. Ledizet, T.M. Fahmy, TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis, J. Immunol. 185 (2010) 2989-2997.
43. D. Doroud, F. Zahedifard, A. Vatanara, A.R. Najafabadi, Y. Taslimi, R. Vahabpour, F. Torkashvand, B. Vaziri, S. Rafati, Delivery of a cocktail DNA vaccine encoding cys-teine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection, J. Control. Release 153 (2011) 154-162.
44. M.P. Longhi, C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A.M. Salazar, M. Colonna, R.M. Steinman, Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant, J. Exp. Med. 206 (2009) 1589-1602.
45. D. Doroud, F. Zahedifard, A. Vatanara, Y. Taslimi, R. Vahabpour, F. Torkashvand, B. Vaziri, A. Rouholamini Najafabadi, S. Rafati, C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leish-mania major in BALB/c mice, PLoS Negl. Trop. Dis. 5 (2011) e1236.